Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Georg Lenz, Prof.
CONTACT
Lead
Universität Münster
With
A total of 120 patients will be included. 60 days after 20 patients have started the therapy, a safety analysis will be performed to identify early and unexpected side effects of the combination therapy. An interim analysis will be conducted 6 months after recruitment of the 50th patient to check the effectiveness of the therapy. For patients not pretreated with CAR-T cells, an additional and separate efficacy analysis will be performed after the 20th CAR-T naive patient started treatment with loncastuximab tesirine and epcoritamab and had a second response assessment (12 weeks after treatment initiation) by FDG-PET/CT (-/MRI).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted